Edward Thomason, CFA, is an accomplished equity research analyst specializing in healthcare and life sciences. Edward obtained a 1st class degree in Biomedical Sciences with honors in pharmacology from The University of Edinburgh and has since held key roles at Informa, Singer Capital Markets, and Liberum, where they focused on detailed research and analysis of pharmaceutical and healthcare companies. Currently, Edward serves as a Senior Manager in Life Science M&A advisory at Deloitte, after previously holding a position as Vice President of Equity Research at Van Lanschot Kempen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices